Regulation of IL-1β-Induced Cyclooxygenase-2 Expression by Interactions of Aβ Peptide, Apolipoprotein E and Nitric Oxide in Human Neuroglioma

被引:0
作者
Anju S. Samy
Orisa J. Igwe
机构
[1] University of Missouri-Kansas City,Division of Pharmacology and Toxicology, UMKC School of Pharmacy
[2] Astellas Pharma US Inc.,undefined
来源
Journal of Molecular Neuroscience | 2012年 / 47卷
关键词
Amyloid β peptide; Cyclooxygenase 2; Apolipoprotein E4; Nitric oxide; Anti-apoE4; Aß12-28; IL-1β; Prostaglandin E2;
D O I
暂无
中图分类号
学科分类号
摘要
Alzheimer disease (AD) is characterized by chronic neuroinflammation, which may lead to dysfunction in neuronal circuits. Although reactive microglia are found in association with accumulation of beta amyloid (Aβ) plaques in the AD brain, their contribution to neuronal cell loss remains speculative. A major genetic risk factor for sporadic AD is inheritance of the apolipoprotein (apo) E4 allele, which has been shown to contribute significantly to neurodegeneration in AD. Many studies have documented the ability of Aβ fibrils in vitro to induce microglia to undergo phenotypic activation, which results in the secretion and/or expression of a plethora of free radicals and pro-inflammatory mediators. These mediators, such as reactive nitrogen/oxygen species and IL-1β as well as cyclooxygenase-2 (COX-2) with associated prostaglandin E2 (PGE2), are believed to be neurotoxic and to contribute to the underlying cause of AD. We have used the human H4 neuroglioma cells as a model astroglial system to examine the interactions between IL-1β and nitric oxide (NO) as co-stimulators of Aβ1–40 in enhancing the expression of COX-2 and production of PGE2 in the presence of recombinant human apolipoprotein E4 (apoE4). Neither Aβ1–40 nor its reverse sequence analog Aβ40–1 alone had a significant effect on COX-2 expression and PGE2 production in the cells. In contrast, after co-incubation with apoE4, Aβ1–40 increased IL-1β-induced COX-2 expression and PGE2 production. Aβ12–28, which binds with high affinity to apoE4, blocked apoE4-mediated effects on Aβ1–40. Furthermore, (±)-S-Nitroso-N-acetylpenicillamine (SNAP), an agent that releases nitric oxide (NO) in situ, alone did not affect IL-1β-induced COX-2 expression, but increased PGE2 production only. Addition of Aβ1–40 preincubated with apoE4 to H4 cells in the presence of SNAP led to an additive IL-1β-induced COX-2 expression and PGE2 production. These observations indicate that increased PGE2 resulted from increased nitrosative stress, which is enhanced by apoE4. Thus a molecular understanding of the interactions of apoE4 with Aβ, NO and IL-1β on the regulation of the COX-2/prostaglandin pathway may open new avenues in understanding the mechanism of development of neurodegenerative disease such as AD.
引用
收藏
页码:533 / 545
页数:12
相关论文
共 337 条
[1]  
Balboa MA(2001)Inflammatory activation of prostaglandin production by microglial cells antagonized by amyloid peptide Biochem Biophys Res Commun 280 558-560
[2]  
Balsinde J(2001)(2001) COX-2 as a multifunctional neuronal modulator Nat Med 7 414-415
[3]  
Dennis EA(1994)Peroxynitrite versus hydroxyl radical: the role of nitric oxide in superoxide-dependent cerebral injury Ann N Y Acad Sci 17 69-75
[4]  
Bazan NG(1996)Inflammatory processes and antiinflammatory drugs in Alzheimer’s disease: a current appraisal Neurobiol Aging 17 789-794
[5]  
Beckman JS(1996)Conformations of synthetic beta peptides in solid state and in aqueous solution: relation to toxicity in PC12 cells Biochim Biophys Acta 1315 40-46
[6]  
Breitner JC(2002)Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death Neurobiol Aging 23 655-664
[7]  
Buchet R(2002)Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer’s disease brain exists J Alzheimers Dis 4 193-201
[8]  
Tavitian E(2000)Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease Neuroscience 97 207-210
[9]  
Ristig D(1994)Brain interleukin-1 beta in Alzheimer’s disease and vascular dementia Methods Find Exp Clin Pharmacol 16 141-151
[10]  
Swoboda R(2005)The interaction of amyloid-beta with ApoE Subcell Biochem 38 255-272